Indian Companies Look To Emphasize Drug Technology Advantages Rather Than Cost Savings With MNCs
This article was originally published in PharmAsia News
Executive Summary
FRANKFURT, Germany - Indian drug companies are sharpening their focus on technology to take contract manufacturing and service capabilities to a stage where multinational companies will look to partner for reasons other than cost savings